<DOC>
	<DOCNO>NCT00848731</DOCNO>
	<brief_summary>This study test hypothesis patient acute PE dyspnea safely inhale NO . The secondary hypothesis patient blind inhaled NO concentration sustain subjective improvement perception dyspnea base upon report Borg dyspnea score , inhalation NO . Specific aim 1 . Test patient acute PE shortness breath severity ≥ 5 0-10 scale call Borg score inhale nitric oxide administer via nasal cannula face mask titration protocol increase concentration 5 ppm 5 min step maximum 25 ppm . 2 . We measure number patient meet absolute safety endpoint titration . An absolute safety endpoint require execution rapid wean protocol ( 2 ppm decrease per minute 0 ppm ) . Absolute safety endpoint : Two consecutive SBP measurement one min apart read &lt; 80 mm Hg ; SaO 2 &lt; 80 % 15 second ; Patient deterioration define : Clinical decision need inotropic pressor support reason , seizure , new alter mental status , focal neurological sign suggestive cerebral ischemia , evidence myocardial ischemia , protract vomit . 3 . Test patient-reported Borg score decrease administration NO . Patients tell detail time titration make aware iNO concentration Borg score assess .</brief_summary>
	<brief_title>Phase I Trial Inhaled Nitric Oxide Treat Acute Pulmonary Embolism</brief_title>
	<detailed_description>We propose enroll total 25 patient recently diagnose pulmonary embolism . Inclusion criterion include moderate severe shortness breath rat patient standard score system , systolic blood pressure &gt; 89 mm Hg unless patient know prior history low blood pressure , blood oxygen saturation &gt; 80 % . Exclusion criterion include : altered mental status , inability use nasal cannula , large need supplemental oxygen , pregnancy , pneumothorax , recent use nitrate-containing medication , recent use thrombolytic drug , requirement inotropic pressor support , level methemoglobin great 10 % . After obtain informed consent , subject blood drawn vital sign obtain . They subsequently begin breathe oxygen NO supply nasal cannula deliver iNOvent device . The patient undergo serial measurement blood pressure , arterial oxygen saturation serum methemoglobin level monitor via non-invasive probe . Titration amount NO deliver make periodically base patient 's vital sign . If absolute safety endpoint reach , NO rapidly wean . Based patient 's response NO determine vital sign , maintenance dose NO , exceed 25 ppm , reach . Subjects continue receive concentration 2 hour prior wean . Patients ask rate severity shortness breath blood drawn prior wean . Should patient reach safety endpoint , NO wean earlier timepoint . We determine percentage patient able complete full protocol without reach safety endpoint , percent change methemoglobin level , trend patient-reported shortness breath , percent change SBP oxygen saturation number patient withdraw induction reason .</detailed_description>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>1 . Diagnosis acute PE require symptom PE present &lt; 14 day CT angiography interpret positive acute PE . Initial evaluation PE must predicate upon investigation new unexplained cardiopulmonary chestrelated clinical feature consistent PE , include shortness breath , chest pain , respiratory distress , dizziness , unexplained tachypnea , tachycardia , syncope , cough hemoptysis . All patient must CT chest angiography &lt; 2 mm collimation , ( 36 ) without indirect venography . Pulmonary arterial opacification achieve power injection nonionic , low osmolar contrast antecubital vein time run ; pitch , voltage , gantry speed technical detail appropriate scanner . ( 37 ; 38 ) Images interpret positive intrapulmonary arterial filling defect consistent acute PE use publish definition ( 37 ; 38 ) boardcertified radiologist specialty training body CT emergency medicine imaging case . 2 . SBP ( SBP ) &gt; 89 mm Hg time enrollment . We allow enrollment patient SBP &lt; 90 mm Hg prior enrollment , patient SBP &gt; 80 mm Hg , patient document patientidentified history low blood pressure symptom shock , describe Jones et al . ( 39 ) 3 . SaO2 % &gt; 80 % time enrollment . 4 . Patients must Borg score great 4/10 . 1 . Altered mental status unable provide consent . 2 . Inability use nasal cannula face mask ( e.g. , anatomic defect ) 3 . Supplemental oxygen requirement great administer via nasal cannula face mask order maintain SaO2 &gt; 80 % . 4 . Pregnancy 5 . Pneumothorax decompression 6 . A serum mtHb great 10 % 7 . Concurrent therapy include : 1 . Viagra® ( sildenafil ) use within past 24 hour 2 . Levitra® ( vardenafil ) use within past 24 hour 3 . Cialis® ( tadalafil ) use within past 72 hour 4 . Use nitroprusside nitroglycerine past 4 hour 5 . Concomitant use pressor inotropic agent 6 . Use fibrinolytic agent past 14 day 7 . Use nitrate within past 24 hour</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>pulmonary hypertension</keyword>
	<keyword>venous thromboembolism</keyword>
</DOC>